Skip to main content
Watch Insiders
UTHRHealthcare

United Therapeutics Corp (UTHR) Insider Trading

In the last 90 days, 4 United Therapeutics Corp (UTHR) insiders reported no open-market purchases and 72 sales totaling $330,860,006. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Nov 9, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Nov 9, 2026Christopher PatuskyDirectorSale1,210$580.00$701,800
Nov 9, 2026Martine A RothblattChairperson & CEOSale1,614$584.59$943,521
Nov 9, 2026Martine A RothblattChairperson & CEOSale7,886$572.69$4,516,253
Nov 6, 2026Martine A RothblattChairperson & CEOSale9,500$564.51$5,362,824
Nov 5, 2026Paul A MahonEVP & GENERAL COUNSELSale8,300$598.67$4,968,933
Nov 5, 2026Martine A RothblattChairperson & CEOSale1,960$597.76$1,171,609
Nov 5, 2026Martine A RothblattChairperson & CEOSale7,540$573.89$4,327,122
Nov 4, 2026Martine A RothblattChairperson & CEOSale1,723$611.06$1,052,854
Nov 4, 2026Martine A RothblattChairperson & CEOSale7,777$599.64$4,663,396
Nov 3, 2026Martine A RothblattChairperson & CEOSale9,500$601.92$5,718,264
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

UTHR insider trading FAQ

Are UTHR insiders buying or selling?
Over the last 90 days, UTHR insiders were net sellers, reporting $0.00 of open-market purchases and $330,860,006 of sales.
When was the last UTHR insider purchase?
No open-market insider purchase of United Therapeutics Corp stock was reported in the last 90 days.
Where does UTHR insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that United Therapeutics Corp officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.